Treatment of bladder cancer in the elderly

by Annette Erlich, Alexandre R. Zlotta
Published 2016-06-01

Tamsulosin oral controlled absorption system (OCAS) in the treatment of benign prostatic hypertrophy

by Mischel G Neill, Rohan Shahani, Alexandre R Zlotta
Published 2008-03-01

Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have Not

by Otto Hemminki, Nathan Perlis, Johan Bjorklund, Antonio Finelli, Alexandre R. Zlotta, Akseli Hemminki
Published 2020-12-01

Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression

by Shivani Kamdar, Ruth Isserlin, Theodorus Van der Kwast, Alexandre R. Zlotta, Gary D. Bader, Neil E. Fleshner, Bharati Bapat
Published 2019-03-01

Systematic review and meta-analysis on trimodal therapy versus radical cystectomy for muscle-invasive bladder cancer: Does the current quality of evidence justify definitive conclu...

by Marian S Wettstein, Jasjit K Rooprai, Clinsy Pazhepurackel, Christopher J D Wallis, Zachary Klaassen, Elizabeth M Uleryk, Thomas Hermanns, Neil E Fleshner, Alexandre R Zlotta, Girish S Kulkarni
Published 2019-01-01

Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer

by Ekaterina Olkhov-Mitsel, Andrea J. Savio, Ken J. Kron, Vaijayanti V. Pethe, Thomas Hermanns, Neil E. Fleshner, Bas W. van Rhijn, Theodorus H. van der Kwast, Alexandre R. Zlotta, Bharati Bapat
Published 2017-04-01

Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille...

by Sultan S Alkhateeb, Mischel Neill, Sas Bar-Moshe, Bas Van Rhijn, David M Kakiashvili, Neil Fleshner, Michael Jewett, Michel Petein, Claude Schulman, Sally Hanna, Peter J Bostrom, Thierry Roumeguere, Shahrokh F Shariat, Sandrine Rorive, Alexandre R Zlotta
Published 2011-01-01

Clinicopathologic factors that influence prognosis and survival outcomes in men with metastatic castration‐resistant prostate cancer treated with Radium‐223

by Esmail M. Al‐Ezzi, Husam A. Alqaisi, Marco A. J. Iafolla, Lisa Wang, Srikala S. Sridhar, Adrian G. Sacher, Nazanin Fallah‐Rad, Di M. Jiang, Geoffrey A. Watson, Charles N. Catton, Padraig R. Warde, Rob J. Hamilton, Neil E. Fleshner, Alexandre R. Zlotta, Aaron R. Hansen
Published 2021-09-01

A feed forward loop enforces YAP/TAZ signaling during tumorigenesis

by Mandeep K. Gill, Tania Christova, Ying Y. Zhang, Alex Gregorieff, Liang Zhang, Masahiro Narimatsu, Siyuan Song, Shawn Xiong, Amber L. Couzens, Jiefei Tong, Jonathan R. Krieger, Michael F. Moran, Alexandre R. Zlotta, Theodorus H. van der Kwast, Anne-Claude Gingras, Frank Sicheri, Jeffrey L. Wrana, Liliana Attisano
Published 2018-08-01